Skip to content
Monday, November 9, 2026
Luckra Connect provides UK professionals with networking op…

The Zimbabwean Government Rejects ‘Unbalanced’ US Health Aid Package Over Data Apprehensions

Medical aid illustration
The proposed US funding was intended for programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has rejected a significant US health deal valued at $367m (272 million pounds) over five years due to Washington's demand for sensitive data.

This rejection came to light after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "skewed".

An official representative later stated that the US was requesting health data for scientific study and commercial gain but refused to share the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged continued negotiations to reach a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.

Wider Background

This development follows a similar situation in Kenya, where a high court suspended a related health funding agreement after concerns were raised about the security of Kenyans' health data.

Since returning to office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and accountability.

According to reports, 16 nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn of fresh investment.

Details of the Rejected Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.

"Effectively, our nation would supply the basic resources for medical research without any assurance that the resulting innovations would be accessible to our population should a future health crisis emerge."

Sovereignty and International Frameworks

He also said that the American exit from the global health body and its push of bilateral health agreements were upending systems previously set up through the international health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.

"This mechanism is intended to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."

These objections regarding the US deal "are not meant as opposition to America," he added.

"We encourage continued discussions with our US partners on how subsequent collaboration might be designed in a way that respects the sovereignty and dignity of each country."

Health Experts Reaction

Medical experts expressed it acknowledged the government's concerns, but recommended that negotiations must proceed given that much of the nation's HIV programmes relied on external financing.

"In cases where technical issues arise, including those involving data governance or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," the group said.

The halted deal emphasises the continuing tensions between receiving much-needed international aid and protecting a country's data in an increasingly data-driven world.

DP
Written by

Debra Perkins

A seasoned business strategist and networking expert with over a decade of experience in UK corporate environments.

Luckra Connect

Type to search articles.